FDA Lays Out Proposed Ground Rules for Natural History Studies

Drug Industry Daily
Drug sponsors who want to use natural histories to help develop treatments for rare diseases should draw up well-defined statistical analysis plans and probably even hire statisticians to help develop the histories, the FDA said in new draft guidance issued Friday.

To View This Article:


Subscribe To Drug Industry Daily